sr141716 has been researched along with naloxone in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (16.36) | 18.2507 |
2000's | 32 (58.18) | 29.6817 |
2010's | 14 (25.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bánki, L; Deli, MA; Dvorácskó, S; Horváth, G; Kékesi, G; Keresztes, A; Macedonio, G; Mollica, A; Pieretti, S; Stefanucci, A; Tömböly, C; Tuboly, G; Walter, FR; Zádor, F | 1 |
Le Fur, G; Michaud, JC; Soubrié, P; Terranova, JP | 1 |
Brown, RE; Dastur, FN; McGregor, IS; McLellan, RA | 1 |
French, ED | 1 |
Di Chiara, G; Pontieri, FE; Tanda, G | 1 |
Coutts, AA; Pertwee, RG | 1 |
Chowen, J; de Fonseca, FR; del Arco, I; Koob, GF; Martin, Y; Navarro, M; Roberts, AJ; Rocío A Carrera, M; Villanúa, MA | 1 |
Gallate, JE; McGregor, IS | 1 |
Gallate, JE; Mallet, PE; McGregor, IS; Saharov, T | 1 |
Corchero, J; Fuentes, JA; Manzanares, J | 1 |
Keniston, L; Lu, J; Mao, J; Mayer, DJ; Price, DD | 1 |
Kirkham, TC; Williams, CM | 1 |
Braida, D; Parolaro, D; Pozzi, M; Sala, M | 1 |
Clarke, RW; Harris, J; Jenkins, S; Witton, SK | 1 |
Capasso, F; Capasso, R; Di Carlo, G; Izzo, AA; Mascolo, N; Pinto, L | 1 |
Caneparo, A; Da Nascimento, S; Le Fur, G; Mas-Nieto, M; Noble, F; Pommier, B; Roques, BP; Tzavara, ET | 1 |
Carrera, MR; Chowen, JA; Cossu, G; del Arco, I; Fattore, L; Fratta, W; Gomez, R; Koob, GF; Maldonado, R; Navarro, M; Rodriguez de Fonseca, F; Valverde, O; Villanua, MA | 1 |
Braida, D; Cavallini, R; Pozzi, M; Sala, M | 1 |
Capasso, F; Capasso, R; Di Marzo, V; Fezza, F; Izzo, AA; Mascolo, N; Pinto, A | 1 |
Mukherjee, M; Robertson, K; Rowland, NE | 1 |
Pietras, TA; Rowland, NE | 1 |
Brunetti, G; Carai, MA; Colombo, G; Gessa, GL; Serra, S; Vacca, G | 1 |
De Miguel, R; Fernández, B; Gomez, N; Guaza, C; Ramos, JA; Romero, EM; Sagredo, O; Urigüen, L; Viveros, MP | 1 |
Assini, FL; Ramos, GA; Takahashi, RN | 1 |
Gallate, JE; Mallet, PE; McGregor, IS | 1 |
Cox, ML; Welch, SP | 1 |
Niederhoffer, N; Pfitzer, T; Szabo, B | 1 |
Borrelli, F; Capasso, F; Capasso, R; Izzo, AA; Mascolo, N | 1 |
Cossu, G; Deiana, S; Fadda, P; Fattore, L; Fratta, W; Spano, MS | 1 |
Braida, D; Iosuè, S; Pegorini, S; Sala, M | 1 |
Cossu, G; Deiana, S; Fadda, P; Fattore, L; Fratta, W; Spano, S | 1 |
Maor, Y; Mechoulam, R; Pertwee, RG; Stevenson, LA; Thomas, A | 1 |
Amico, MC; Morrone, LA; Palmery, M; Romanelli, L; Tucci, P; Valeri, P | 1 |
Adrian, R; Baratta, J; Giuffrida, A; Piomelli, D; Solbrig, MV | 1 |
De Vries, TJ; Hogenboom, F; Schoffelmeer, AN; Wardeh, G | 1 |
Evenden, J; Ko, T | 1 |
Trezza, V; Vanderschuren, LJ | 1 |
Canals, M; Milligan, G | 1 |
Blundell, JE; Rodgers, RJ; Tallett, AJ | 1 |
Inno, J; Kurrikoff, K; Matsui, T; Vasar, E | 1 |
Baarendse, PJ; Trezza, V; Vanderschuren, LJ | 1 |
Allen, CP; Lang, ST; Leri, F; Manwell, LA; Parker, LA; Satvat, E | 1 |
Dimitrov, EL; Petrus, E; Usdin, TB | 1 |
Castelli, MP; Ennas, MG; Lecca, S; Luchicchi, A; Melis, M; Muntoni, AL; Pistis, M | 1 |
Fadda, P; Fattore, L; Fratta, W; Melis, V; Spano, M | 1 |
Hillman, C; Rasmussen, EB | 1 |
Lecca, S; Luchicchi, A; Melis, M; Muntoni, AL; Pistis, M | 1 |
Craft, RM; Laggart, JD; Tsutsui, KT; Wakley, AA | 1 |
Rodgers, RJ; Wright, FL | 1 |
Lockie, SH; Oldfield, BJ; Stefanidis, A; Tschöp, MH | 1 |
Davies, AJ; Kim, D; Lee, JY; Oh, SB; Park, J; Pickering, AE; Vang, H | 1 |
Kang, Y; Kim, D; Lee, GJ; Lee, JY; Lee, PR; Oh, SB; Won, CH | 1 |
55 other study(ies) available for sr141716 and naloxone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalins; Indoles; Mice; Molecular Structure; Naphthalenes; Oxycodone; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Structure-Activity Relationship | 2019 |
Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Endocannabinoids; Evoked Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Morpholines; Naloxone; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1995 |
Cannabinoid modulation of rat pup ultrasonic vocalizations.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Body Temperature; Cannabinoids; Cyclohexanols; Dopamine Antagonists; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; Hypothermia; Motor Activity; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rimonabant; Vocalization, Animal | 1996 |
delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
Topics: Animals; Cannabinoids; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Male; Naloxone; Narcotic Antagonists; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant; Stimulation, Chemical; Ventral Tegmental Area | 1997 |
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.
Topics: Animals; Benzoxazines; Dopamine; Dronabinol; Heroin; Male; Microdialysis; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, mu; Rimonabant | 1997 |
Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Topics: Acetylcholine; Benzoxazines; Child, Preschool; Cyclohexanols; Histamine; Humans; In Vitro Techniques; Male; Morpholines; Myenteric Plexus; Naloxone; Naphthalenes; Norepinephrine; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Stereoisomerism | 1997 |
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.
Topics: Animals; Brain Chemistry; Gene Expression; In Situ Hybridization; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, mu; Rimonabant; RNA, Messenger; Substance Withdrawal Syndrome | 1998 |
The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.
Topics: Alcohol Drinking; Animals; Beer; Ethanol; Male; Motivation; Motor Activity; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Ritanserin; Serotonin Antagonists | 1999 |
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
Topics: Animals; Beer; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Drinking Behavior; Ethanol; Male; Motor Activity; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant; Self Administration; Sucrose | 1999 |
Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Corticosterone; Dronabinol; Injections, Intraventricular; Male; Naloxone; Narcotic Antagonists; Piperidines; Pituitary-Adrenal System; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant | 1999 |
Two distinctive antinociceptive systems in rats with pathological pain.
Topics: Analgesics, Non-Narcotic; Animals; Cannabinoids; Dizocilpine Maleate; Dronabinol; Drug Tolerance; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Morphine; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sciatic Nerve | 2000 |
Synergistic efects of opioid and cannabinoid antagonists on food intake.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabinoids; Drug Synergism; Eating; Male; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rimonabant | 2001 |
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzimidazoles; Conditioning, Operant; Cyclohexanols; Heroin; Male; Naloxone; Narcotic Antagonists; Narcotics; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Rimonabant; Self Administration | 2001 |
Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit.
Topics: Animals; Decerebrate State; Dose-Response Relationship, Drug; Dronabinol; Female; Fentanyl; Male; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rabbits; Receptors, Cannabinoid; Receptors, Drug; Reflex; Rimonabant; Spinal Cord; Spinal Cord Injuries | 2001 |
Effect of vanilloid drugs on gastrointestinal transit in mice.
Topics: Alkaloids; Animals; Arachidonic Acids; Benzodioxoles; Capsaicin; Dose-Response Relationship, Drug; Endocannabinoids; Gastrointestinal Transit; Hexamethonium; Male; Mice; Mice, Inbred ICR; Naloxone; NG-Nitroarginine Methyl Ester; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Drug; Rimonabant; Yohimbine | 2001 |
Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.
Topics: Animals; Brain Chemistry; Cannabinoids; Conditioning, Operant; Dynorphins; Male; Mice; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Piperidines; Pyrazoles; Radioimmunoassay; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid, kappa; Rimonabant; Substance Withdrawal Syndrome; Synapses | 2001 |
Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Topics: Animals; Avoidance Learning; Cannabinoids; Caudate Nucleus; Conditioning, Operant; Disease Models, Animal; Heroin; Heroin Dependence; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Putamen; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant; RNA, Messenger; Self Administration; Septum of Brain | 2001 |
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
Topics: Analgesics; Analgesics, Opioid; Animals; Brain; Conditioning, Psychological; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Heroin; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reward; Rimonabant | 2001 |
Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.
Topics: Adrenergic alpha-Antagonists; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Croton Oil; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Gastrointestinal Motility; Gastrointestinal Transit; Hexamethonium; Inflammation; Intestine, Small; Male; Mice; Mice, Inbred ICR; Naloxone; NG-Nitroarginine Methyl Ester; Nicotinic Antagonists; Nitric Oxide Synthase; Palmitic Acids; Phenylmethylsulfonyl Fluoride; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Yohimbine | 2001 |
Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.
Topics: Animals; Dexfenfluramine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Eating; Female; Male; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin Receptor Agonists | 2001 |
Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Eating; Female; Hyperphagia; Male; Naloxone; Narcotic Antagonists; Nociceptin; Opioid Peptides; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2002 |
Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716.
Topics: Alcohol Drinking; Animals; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Piperidines; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2002 |
Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.
Topics: Analgesics; Animals; Behavior, Animal; Cannabinoids; Corticosterone; Cyclohexanols; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Grooming; Male; Marijuana Abuse; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Neostriatum; Neurosecretory Systems; Nociceptors; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sex Characteristics | 2002 |
Anxiety does not affect the antinociceptive effect of Delta 9-THC in mice: participation of cannabinoid and opioid receptors.
Topics: Animals; Anxiety; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Opioid; Rimonabant | 2003 |
Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
Topics: Alcohol Drinking; Animals; Cannabinoids; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Male; Motivation; Naloxone; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 2004 |
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Topics: Animals; Arthritis, Experimental; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Dynorphins; Enkephalin, Leucine; Enkephalin, Methionine; Freund's Adjuvant; Injections, Intradermal; Injections, Intraperitoneal; Male; Morphine; Mycobacterium; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2004 |
Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats.
Topics: Analgesics, Opioid; Anesthesia; Animals; Benzoxazines; Blood Pressure; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cardiovascular Physiological Phenomena; Cisterna Magna; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Heart Rate; Injections; Male; Morpholines; Naloxone; Naphthalenes; Norepinephrine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Respiration; Rimonabant; Tidal Volume | 2004 |
Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Anthracenes; Antidepressive Agents; Atropine; Bridged Bicyclo Compounds; Capsaicin; Depression; Electric Stimulation; Female; Haloperidol; Hypericum; Kaempferols; Male; Methysergide; Muscle Contraction; Muscle, Smooth; Naloxone; Perylene; Phentolamine; Phloroglucinol; Piperidines; Plant Extracts; Propranolol; Pyrazoles; Quercetin; Rats; Rats, Wistar; Rimonabant; Rutin; Terpenes; Tetrodotoxin; Urinary Bladder; Urinary Incontinence; Verapamil | 2004 |
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat.
Topics: Animals; Behavior, Animal; Benzoxazines; Cannabinoids; Cocaine; Extinction, Psychological; Heroin; Male; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Time Factors | 2004 |
Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats.
Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Dronabinol; Injections, Intraventricular; Male; Naloxone; Narcotic Antagonists; Piperidines; Psychotropic Drugs; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration | 2004 |
Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Topics: Animals; Behavior, Addictive; Benzoxazines; Conditioning, Operant; Cyclohexanols; Drug Interactions; Extinction, Psychological; Heroin; Heroin Dependence; Male; Morpholines; Naloxone; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Inbred Strains; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration | 2005 |
Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
Topics: Adenosine Triphosphate; Adrenergic alpha-2 Receptor Antagonists; Animals; Benzoxazines; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Capsaicin; In Vitro Techniques; Isometric Contraction; Male; Mice; Morpholines; Naloxone; Naphthalenes; Phenylephrine; Piperidines; Pyrazoles; Rimonabant; Ruthenium Red; TRPV Cation Channels; Vas Deferens; Yohimbine | 2005 |
Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Analgesics, Opioid; Animals; Benzoxazines; Cholecystokinin; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morpholines; Muscle Contraction; Muscle, Smooth; Naloxone; Naphthalenes; Narcotic Antagonists; Neurons; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid, kappa; Receptors, Opioid, mu; Rimonabant; Substance Withdrawal Syndrome; Theophylline | 2005 |
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Basal Ganglia; Borna Disease; Cannabinoid Receptor Modulators; Convulsants; Disease Models, Animal; Endocannabinoids; Limbic System; Male; Movement Disorders; Naloxone; Narcotic Antagonists; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB1; Rimonabant; Seizures | 2005 |
Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Topics: Animals; Calcium; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Morphine; Naloxone; Narcotic Antagonists; Neural Inhibition; Neurotransmitter Agents; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Rimonabant; Tritium | 2006 |
The effects of anorexic drugs on free-fed rats responding under a second-order FI15-min (FR10:S) schedule for high incentive foods.
Topics: Animals; Appetite; Appetite Depressants; Appetitive Behavior; Body Weight; Dextroamphetamine; Dose-Response Relationship, Drug; Energy Intake; Extinction, Psychological; Feeding Behavior; Fenfluramine; Male; Motivation; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Reinforcement Schedule; Rimonabant | 2007 |
Bidirectional cannabinoid modulation of social behavior in adolescent rats.
Topics: Analgesics, Opioid; Animals; Benzamides; Benzoxazines; Cannabinoids; Carbamates; Dopamine; Dopamine Antagonists; Exploratory Behavior; Flupenthixol; Male; Morphine; Morpholines; Motor Activity; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Play and Playthings; Pyrazoles; Rats; Rats, Wistar; Receptors, Dopamine; Reward; Rimonabant; Social Behavior | 2008 |
Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors.
Topics: Benzoxazines; Cannabinoids; Cell Membrane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Humans; Kinetics; Ligands; Models, Biological; Morpholines; Naloxone; Naphthalenes; Phosphorylation; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Rimonabant | 2008 |
Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Appetite; Behavior, Animal; Body Weight; Cannabinoids; Eating; Grooming; Locomotion; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Reaction Time; Rimonabant; Time Factors | 2008 |
Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin.
Topics: Analgesia; Animals; Brain; Cannabinoid Receptor Modulators; Cholecystokinin; Endocannabinoids; Gene Expression; Gene Expression Regulation; Mice; Mice, Mutant Strains; Naloxone; Narcotic Antagonists; Pain Threshold; Piperidines; Pyrazoles; Receptor, Cholecystokinin B; Receptors, Cannabinoid; Receptors, Opioid; Rimonabant; Spinal Cord; Stress, Psychological | 2008 |
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.
Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior | 2009 |
FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Topics: Amidohydrolases; Animals; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Choice Behavior; Conditioning, Psychological; Dietary Sucrose; Extinction, Psychological; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Rimonabant; Species Specificity; Substance Withdrawal Syndrome | 2009 |
Tuberoinfundibular peptide of 39 residues (TIP39) signaling modulates acute and tonic nociception.
Topics: Amidohydrolases; Animals; Cannabinoid Receptor Modulators; Formaldehyde; In Situ Hybridization; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Knockout; Naloxone; Narcotic Antagonists; Neuropeptides; Nociceptors; Pain; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Parathyroid Hormone, Type 2; Rimonabant; RNA, Messenger; Signal Transduction; Stress, Psychological; Synapses; Vesicular Glutamate Transport Protein 2 | 2010 |
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells.
Topics: Action Potentials; Animals; Animals, Newborn; Behavior, Animal; Benzoxazines; Cocaine; Dopamine; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Illicit Drugs; In Vitro Techniques; Male; Mecamylamine; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Neural Inhibition; Neural Pathways; Neurons; Nicotinic Antagonists; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Time Factors; Ventral Tegmental Area | 2011 |
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazines; Cannabinoids; Drug Substitution; Drug Synergism; Heroin; Male; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Rimonabant; Self Administration | 2011 |
Naloxone and rimonabant reduce the reinforcing properties of exercise in rats.
Topics: Animals; Cannabinoids; Extinction, Psychological; Female; Naloxone; Narcotic Antagonists; Physical Conditioning, Animal; Piperidines; Pyrazoles; Rats; Rats, Zucker; Reinforcement, Psychology; Rimonabant | 2011 |
Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse.
Topics: Action Potentials; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Cocaine; Dopaminergic Neurons; Electric Stimulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tegmentum Mesencephali; Time Factors; Ventral Tegmental Area | 2012 |
Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Topics: Analgesics; Animals; Camphanes; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Female; Male; Morphine; Motor Activity; Naloxone; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sex Characteristics | 2012 |
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
Topics: Animals; Appetite; Behavior, Animal; Body Weight; Cannabinoid Receptor Antagonists; Compulsive Behavior; Dose-Response Relationship, Drug; Feeding Behavior; Food; Grooming; Locomotion; Male; Naloxone; Narcotic Antagonists; Piperidines; Pruritus; Pyrazoles; Rats; Rimonabant | 2013 |
Combination cannabinoid and opioid receptor antagonists improves metabolic outcomes in obese mice.
Topics: Animals; Body Composition; Cannabinoid Receptor Antagonists; Drug Therapy, Combination; Glucose; Insulin; Male; Mice; Mice, Obese; Naloxone; Narcotic Antagonists; Obesity; Piperidines; Pyrazoles; Rimonabant; Thermogenesis; Treatment Outcome | 2015 |
Hedonic drinking engages a supraspinal inhibition of thermal nociception in adult rats.
Topics: Animals; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Freund's Adjuvant; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Naloxone; Narcotic Antagonists; Pain Threshold; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reaction Time; Rimonabant; Spinal Cord; Sucrose; Sweetening Agents; Water Deprivation | 2019 |
The analgesic effect of refeeding on acute and chronic inflammatory pain.
Topics: Acute Pain; Analgesics, Opioid; Animals; Chronic Pain; Disease Models, Animal; Eating; Food Deprivation; Formaldehyde; Freund's Adjuvant; Glucose; Hot Temperature; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Naloxone; Narcotic Antagonists; Pain Management; Pain Measurement; Rimonabant | 2019 |